Eupraxia Pharmaceuticals Inc
(EPRX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | |
| Operating Expenses | 27,003 | 27,847 | 17,618 |
| Operating Income | -27,003 | -27,847 | -17,618 |
| Interest Expense | 604 | 1,170 | 983 |
| Other Income | 1,864 | 88 | -390 |
| Pre-tax Income | -25,743 | -28,930 | -18,991 |
| Income Tax | 2 | 36 | N/A |
| Net Income Continuous | -25,745 | -28,966 | -18,991 |
| Minority Interests | -242 | -745 | -501 |
| Net Income | $-25,503 | $-28,221 | $-18,490 |
| EPS Basic Total Ops | -0.76 | -1.17 | -0.96 |
| EPS Basic Continuous Ops | -0.76 | -1.20 | -0.98 |
| EPS Diluted Total Ops | -0.76 | -1.17 | -0.96 |
| EPS Diluted Continuous Ops | -0.76 | -1.20 | -0.98 |
| EPS Diluted Before Non-Recurring Items | -0.76 | -1.17 | N/A |
| EBITDA(a) | $-26,832 | $-27,692 | $-17,470 |